Cornerstone Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Cornerstone Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,270	Closed	-$578K	–	239
2023 Q4	$578K	Sell	11,270 -127	-1%	-$6.67K	0.03%	64
2023 Q3	$661K	Sell	11,397 -105	-0.9%	-$6.43K	0.04%	55
2023 Q2	$736K	Hold	11,502	–	–	0.05%	52
2023 Q1	$797K	Hold	11,502	–	–	0.05%	53
2022 Q4	$828K	Sell	11,502 -36	-0.3%	-$2.71K	0.05%	54
2022 Q3	$820K	Hold	11,538	–	–	0.06%	53
2022 Q2	$888K	Sell	11,538 -3,175	-22%	-$242K	0.06%	53
2022 Q1	$1.07M	Sell	14,713 -714,164	-98%	-$48M	0.06%	51
2021 Q4	$45.4M	Buy	728,877 +47,943	+7%	+$2.81M	2.52%	24
2021 Q3	$40.3M	Sell	680,934 -66,848	-9%	-$4.4M	2.33%	25
2021 Q2	$50M	Sell	747,782 -11,990	-2%	-$782K	2.61%	25
2021 Q1	$48M	Buy	759,772 +141,372	+23%	+$8.8M	2.58%	23
2020 Q4	$38.4M	Buy	618,400 +64,997	+12%	+$4M	2.33%	24
2020 Q3	$33.4M	Buy	553,403 +544,248	+5,945%	+$32.8M	2.34%	23
2020 Q2	$538K	Sell	9,155 -35	-0.4%	-$2.09K	0.04%	69
2020 Q1	$512K	Sell	9,190 -32	-0.3%	-$1.96K	0.03%	65
2019 Q4	$592K	Hold	9,222	–	–	0.03%	67
2019 Q3	$468K	Hold	9,222	–	–	0.02%	69
2019 Q2	$418K	Sell	9,222 -542	-6%	-$25.2K	0.02%	73
2019 Q1	$466K	Buy	9,764 +133	+1%	+$6.63K	0.02%	70
2018 Q4	$501K	Sell	9,631 -39	-0.4%	-$2.1K	0.02%	64
2018 Q3	$600K	Buy	9,670 +111	+1%	+$6.59K	0.03%	66
2018 Q2	$529K	Hold	9,559	–	–	0.02%	70
2018 Q1	$605K	Sell	9,559 -25	-0.3%	-$1.61K	0.03%	69
2017 Q4	$587K	Hold	9,584	–	–	0.03%	68
2017 Q3	$611K	Hold	9,584	–	–	0.03%	62
2017 Q2	$534K	Buy	9,584 +584	+6%	+$31.8K	0.02%	71
2017 Q1	$489K	Hold	9,000	–	–	0.02%	73
2016 Q4	$526K	Hold	9,000	–	–	0.02%	63
2016 Q3	$485K	Sell	9,000 -193	-2%	-$12.4K	0.02%	64
2016 Q2	$676K	Sell	9,193 -2,200	-19%	-$155K	0.02%	59
2016 Q1	$728K	Hold	11,393	–	–	0.02%	62
2015 Q4	$784K	Hold	11,393	–	–	0.02%	59
2015 Q3	$674K	Hold	11,393	–	–	0.02%	64
2015 Q2	$758K	Hold	11,393	–	–	0.02%	60
2015 Q1	$735K	Buy	11,393 +193	+2%	+$12.1K	0.01%	67
2014 Q4	$661K	Hold	11,200	–	–	0.01%	64
2014 Q3	$573K	Hold	11,200	–	–	0.01%	62
2014 Q2	$543K	Hold	11,200	–	–	0.01%	63
2014 Q1	$582K	Sell	11,200 -1,000	-8%	-$53.2K	0.01%	58
2013 Q4	$648K	Hold	12,200	–	–	0.01%	56
2013 Q3	$565K	Hold	12,200	–	–	0.01%	51
2013 Q2	$545K	Buy	+12,200	New	+$530K	0.01%	54

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cornerstone Investment Partners's BMY Position: Q1 2024 in Review

Cornerstone Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 11,270 shares — an estimated $578K sold.

Cornerstone Investment Partners first reported a position in BMY in Q2 2013 and held it in 43 quarters. The position peaked at $50M in Q2 2021. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Cornerstone Investment Partners reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Cornerstone Investment Partners sold 11,270 Bristol-Myers Squibb shares in Q1 2024, an estimated $578K.
Cornerstone Investment Partners first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 43 quarters.
Cornerstone Investment Partners's Bristol-Myers Squibb position peaked at $50M in Q2 2021.
2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Cornerstone Investment Partners's 13F filing for Q1 2024, filed 29 Apr 2024.